semaglutide period side effects For Weight Loss Effects: A Comprehensive 2026 Safety Guide Tirzepatide vs. Semaglutide for Weight

SGT-212SGT-212 / Gene Therapy / NeuromuscularFriedreich's ataxia (FA)Phase 1/2ActiveGlobal SGT-501SGT-501 / Gene Therapy / CardiacRYR2-Mediated CPVTPhase 1/2ActiveGlobalCASQ2-Mediated CPVTPreclinicalActiveGlobal SGT-601SGT-601 / TNNT2 / Gene Therapy / CardiacTNNT2-Mediated Dilated Cardiomyopathy (DCM)PreclinicalActiveGlobal SGT-401SGT-401 / BAG3 / Gene Therapy / CardiacBAG3-Mediated Dilated Cardiomyopathy (DCM)PreclinicalActiveGlobal SGT-701SGT-701 / RBM20 / Gene Therapy / CardiacRBM20-Mediated Dilated Cardiomyopathy (DCM)PreclinicalActiveGlobal Undisclosed Cardiac TargetsGene Therapy / CardiacGenetic cardiomyopathies and channelopathiesDiscoveryActiveGlobal 7assets SPY001SPY001 / 47 / Monoclonal antibody / GastroenterologyInflammatory Bowel Disease (IBD)Ulcerative Colitis SPY002SPY002 / TL1A / Monoclonal antibody / Gastroenterology / RheumatologyInflammatory Bowel Disease (IBD)Rheumatoid Arthritis (RA) SPY003SPY003 / IL-23 / Monoclonal antibody / GastroenterologyInflammatory Bowel Disease (IBD) SPY120SPY120 / 47 + TL1A / Combination / GastroenterologyInflammatory Bowel Disease (IBD) SPY130SPY130 / 47 + IL-23 / Combination / GastroenterologyInflammatory Bowel Disease (IBD) SPY230SPY230 / TL1A + IL-23 / Combination / GastroenterologyInflammatory Bowel Disease (IBD)Ulcerative Colitis SPY072SPY072 / TL1A / Monoclonal antibody / RheumatologyRheumatoid Arthritis (RA)Psoriatic Arthritis (PsA)Axial Spondyloarthritis (axSpA) 7assets 7assets 7assets VY7523VY-TAU01 / Tau / Monoclonal Antibody / NeurologyAlzheimer's DiseasePhase 1OngoingUnited States VY1706Tau / AAV Gene Therapy / NeurologyAlzheimer's DiseaseIND-EnablingOngoingUnited States APOE Gene TherapyAPOE / AAV Gene Therapy / NeurologyAlzheimer's DiseasePreclinicalOngoing NBIB-'223NBIB-223 / Frataxin (FXN) / AAV Gene Therapy / NeurologyFriedreich's Ataxia (FA)IND-EnablingOngoing GBA1 Gene TherapyGBA1 / AAV Gene Therapy / NeurologyParkinson's Disease and GBA1-mediated diseasesIND-EnablingOngoing Novartis Partnered ProgramsUndisclosed / AAV Gene Therapy / NeurologyHuntington's Disease, Spinal Muscular Atrophy (SMA), UndisclosedPreclinicalOngoing Alexion Partnered ProgramUndisclosed / AAV Gene Therapy / NeurologyUndisclosed Neurological DiseasePreclinicalOngoing 6assets RemlifanserinACP-204 / 5-HT2A receptor / inverse agonist / Neurological DisordersAlzheimers Disease PsychosisPhase 2RecruitingLewy Body Dementia with PsychosisPhase 2 ACP-211ACP-211 / selectively deuterated R-norketamine / Neurological DisordersMajor Depressive DisorderPhase 2 ACP-711ACP-711 / GABAA 3 / modulator / Neurological DisordersEssential TremorPhase 1 ACP-271ACP-271 / GPR88 / agonist / Neurological Disorders

Understanding the underlying mechanisms can help patients and clinicians address these symptoms appropriately

10.1016/j.biomaterials.2012.04.061 16 EjtehadifarM.ShamsasenjanK.MovassaghpourA.AkbarzadehlalehP.DehdilaniN.AbbasiP.et al (2015)

It could be the fact that the hand or finger is not exposed to things out in the world

Over the first few months, she said, she lost about 40 pounds

Access is provided after a proposal has been approved by an independent review committee identified for this purpose and after receiving a signed data sharing agreement